← Russell 3000 cross-section

UNH UNITEDHEALTH GROUP INC

Trailing twelve months to 2026-06-30 · as filed 2026-08-10, not restated
Financials

Scale

Market cap
$357.0bn
Revenue TTM
$450.1bn
Net income TTM
$14.1bn
Free cash flow
$23.6bn
Composite score
37.9
Sector rank
#34

Valuation

P / E
25.3
EV / EBITDA
EV / sales
0.9
FCF yield
6.62%
Earnings yield vs 10-yr
-0.77pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
3.1%
EBITDA margin
ROE
13.5%
ROIC
14.8%
Revenue growth
6.5%

Insider activity, last 90 days

Net open-market
$-0.66m
Buyers
0
Sellers
1

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

For the six months ended June 30, 2026, these items increased operating costs by $415 million, partially offset by a $75 million increase to investment and other income and $187 million decrease in medical costs, as reflected on the Condensed Consolidated Statements of Operations. Business Trends Our businesses participate primarily in the United States health markets. As a result of increased pricing in response to anticipated care patterns in 2026, the exit from certain markets and decreased people served through UnitedHealthcare Medicare Advantage offerings, the number of people served under value-based care arrangements has contracted and is expected to continue throughout 2026. …UNITEDHEALTH GROUP INC, 10-Q, period ended 2026-06-30, filed 2026-08-10

Read the full passage →